The Board inter alia, considered and approved the amalgamation of Gabs Investments Private Limited (Gabs') with Ajanta Pharma Limited (APL') in consideration for Equity shares of APL. The proposed amalgamation would be carried out vide a Scheme of Amalgamation and Arrangement between Gabs Investments Private Limited and Ajanta Pharma Limited and their respective Shareholders (the Scheme') under Sections 230-232 read with Section 52 and Section 66 of the Companies Act, 2013 and other applicable provisions of the Companies Act, 1956 / Companies Act, 2013. The Board inter alia, considered and approved the amalgamation of Gabs Investments Private Limited (Gabs') with Ajanta Pharma Limited (APL') in consideration for Equity shares of APL. The proposed amalgamation would be carried out vide a Scheme of Amalgamation and Arrangement between Gabs Investments Private Limited and Ajanta Pharma Limited and their respective Shareholders (the Scheme') under Sections 230-232 read with Section 52 and Section 66 of the Companies Act, 2013 and other applicable provisions of the Companies Act, 1956 / Companies Act, 2013. Scheme of Amalgamation and Arrangement between Gabs Investments Private Limited and Ajanta Pharma Limited and their respective shareholders ('Scheme')3 We would like to inform that the Hon'ble National Company Law Tribunal, Mumbai Bench ('NCLT') did not deem it fit to approve and sanction the proposed Scheme. The copy of the order pronounced by the Hon'ble NCLT was made available to the Company by the Counsel of the Company on 7th September, 2018. (As Per BSE Announcement Dated on 10.09.2018)